| |
Welcome to the Compulsive
Gambling File
Patients all over the world
have used the information in The Compulsive Gambling File since
1992, when the Center for Current Researchone of the first
80 companies on the Internetwas founded. Our highly trained
researchers (all of whom hold Ph.D.s) have searched the advanced
medical database at the National Library of Medicine and compiled
a comprehensive collection of research descriptions on Compulsive
Gambling and its care.
As you will see, the following research descriptions detail the
findings published in the most respected journals in the field.
Because the research descriptions are written in medical terms,
most people will bring all or parts of the Compulsive Gambling File to their doctor for further explanation and discussion.
Often your doctor will have access to full-text articles and
other information that could be useful in planning a successful
course of treatment and prevention. Note that the titles of the
journals are abbreviated according to the National Library of
Medicine's format; your doctor can provide the full title if
you need it.
Thank you for accessing the Compulsive Gambling File. We truly
hope the information fosters better health.
Sincerely,
Gregory A. Fraser, Ph.D.
Director of Research
Important Note: The following information
is provided for your education. It should not be relied upon for
personal diagnosis or treatment. If you believe that a
particular therapy applies to you or someone you care about, be
sure to consult a doctor before trying it.
On Downloading (Please Read
Carefully)
To
download or print the Compulsive
Gambling File, point your mouse to "File" in the top bar of your
Explorer or Netscape window, and click once. Now click once on either
"Save As" (download), or "Print" (print), and follow the
appropriate prompts.
Previous Compulsive Gambling
Research: 2002-2006
The
Compulsive Gambling
File also contains summaries of past
research that has shown promise and may still be standard
practice among many physicians.
To
download earlier
research findings on
Compulsive Gambling, click
HERE.
Latest Research on
Compulsive Gambling
J Gambl Stud. 2008 Sep;24(3):393-409. Epub 2008 Jun 17.
Adapted Couple Therapy (ACT) for pathological gamblers: a
promising avenue.
Bertrand K, Dufour M, Wright J, Lasnier B.
Département des Sciences de santé Communautaire, Service de Toxicomanie,
Université de Sherbrooke, Campus de Longueuil, 1111, rue St-Charles Ouest, Tour
Ouest, Bureau 500, Longueuil, QC, Canada J4K 5G4. karine.bertrand@usherbrooke.ca
The study of the effectiveness of treatment for pathological gambling
constitutes a field that is still largely unexplored. To date, the models
assessed primarily target the individual and include little or no involvement of
the family circle. Yet, the deleterious effects of gambling on loved ones and
especially spouses are well recognized. Further, the addition of a couple
modality to individual treatment has been shown to be effective on many levels
in the treatment of substances use disorders. This article therefore proposes a
critical review of (1) the literature providing a better understanding of the
complex interactions between the couple relationship and pathological gambling,
(2) studies on the effects of couple therapies on gamblers and their partners.
We then present the therapeutic model developed by our team of
clinician-researchers in collaboration with actors from Québec clinical
settings: Adapted Couple Therapy (ACT) for pathological gamblers. In the Québec
context, this model will serve as a complement to an individual
cognitive-behavioral treatment model that has been proven effective and is
employed throughout the Canadian province. The assessment of couple therapies
could reveal avenues of solutions to better assist pathological gamblers who
tend to drop-out of treatment and relapse.
------
J Adolesc Health. 2008 Jul;43(1):91-3. Epub 2008 Apr 11.
Gambling initiation in preadolescents.
Hurt H, Giannetta JM, Brodsky NL, Shera D, Romer D.
Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
19104, USA. hurt@email.chop.edu
Gambling has increased in the past decade, with growing opportunities for
initiation by adolescents. More limited data, however, are available regarding
gambling in preadolescents. In the investigation reported here, gambling for
money was the most common risk behavior in 10- to 12-year-olds. Gamblers were
more likely to be white, have tried alcohol, have positive affect toward
gambling, and have friends who gamble.
------
PLoS ONE. 2008 Jun 25;3(6):e2479.
Dopamine agonist increases risk taking but blunts reward-related
brain activity.
Riba J, Krämer UM, Heldmann M, Richter S, Münte TF.
Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany.
The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to
pathological gambling. In a placebo-controlled double-blind study in healthy
volunteers, we observed riskier choices in a lottery task after administration
of the D3 receptor-preferring agonist pramipexole thus mimicking risk-taking
behavior in PD. Moreover, we demonstrate decreased activation in the rostral
basal ganglia and midbrain, key structures of the reward system, following
unexpected high gains and therefore propose that pathological gambling in PD
results from the need to seek higher rewards to overcome the blunted response in
this system.
------
Psychol Addict Behav. 2008 Jun;22(2):257-68.
Subtyping pathological gamblers on the basis of affective
motivations for gambling: relations to gambling problems, drinking problems, and
affective motivations for drinking.
Stewart SH, Zack M, Collins P, Klein RM.
Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
sstewart@dal.ca
Pathological gamblers who drink when gambling (n=158; 77% men; mean age=36.0
years) completed the Inventory of Gambling Situations (IGS) and gambling and
drinking criterion measures. Principal components analysis on the IGS subscales
revealed negative (e.g., Unpleasant Emotions) and positive (e.g., Pleasant
Emotions) gambling situation factors. Subjecting IGS factor scores to cluster
analysis revealed three clusters: (a) enhancement gamblers, with low negative
and high positive factor scores; (b) coping gamblers, with very high negative
and high positive factor scores; and (c) low emotion regulation gamblers, with
low negative and positive factor scores (59%, 23%, and 18% of the sample,
respectively). Clusters were validated with a direct measure of gambling
motives. Additional validity analyses showed that coping gamblers scored higher
than the other groups on a variety of different gambling activities, gambling
problems, drinking frequency, drinking problems, and coping drinking motives,
whereas low emotion regulation gamblers scored lower than the other groups on
gambling frequency, gambling problems, drinking quantity, and enhancement
drinking motives. The findings validate this empirical approach to subtyping
gamblers and suggest consistency of motives across addictive behaviors. 2008 APA
------
Mil Med. 2008 May;173(5):452-9.
Gambling and health risk-taking behavior in a military sample.
Steenbergh TA, Whelan JP, Meyers AW, Klesges RC, DeBon M.
Department of Psychology, Indiana Wesleyan University, 4201 South Washington,
Marion, IN 46953, USA.
This study examined the gambling of a cohort of U.S. Air Force recruits (N =
31,104) and the relationship between their gambling and health-risk behaviors.
Participants provided self-report data regarding gambling and health-related
behaviors. Results suggest that 10.4% of participants gambled weekly or more
often, 6.2% reported gambling problems, and 1.9% acknowledged loss of control
over gambling. Men were more likely than women to report weekly gambling and
possible problematic gambling. Minorities, compared to Caucasians, were more
likely to experience gambling problems and report loss of control. Seven
health-risk behaviors were significant predictors of frequent gambling; however,
considerably fewer health behaviors were uniquely related to problematic
gambling. These results suggest that gambling-related problems within the
military warrant further attention.
------
J Addict Dis. 2008;27(1):33-40.
Personality traits and disorders in pathological gamblers versus
normal controls.
Sáez-Abad C, Bertolín-Guillén JM.
Unit of Mental Health of Torrente (Valencia), Health Department 9, Valencian
Health Agency, Spain.
AIMS: To establish the personality traits and disorders of pathological gamblers
in treatment by means of a descriptive cross-sectional study of two prospective
matched-pair cohorts: 50 pathological gamblers versus a control group of 50
normal volunteers (non-patient and non-pathological gamblers). All the
pathological gamblers of the sample followed treatment as out-patients in the
province of Valencia (Spain-EU). Recruitment period: January-May 2004. MEASURE
INSTRUMENTS: South Oaks Gambling Screen, Barratt Impulsivity Scale, Sensation
Seeking Scale, and Structured Clinical Interview for Personality Disorders of
Axis II of DSM-IV. FINDINGS AND CONCLUSIONS: Male pathological gamblers go more
often to health and social care facilities. Pathological gamblers prefer to play
slot machines, present a higher prevalence of personality disorders, most of
them belonging to cluster B, are more impulsive and higher sensation seekers
than the controls. There are no linear relationships between the severity of
pathological gambling and the traits of impulsivity and sensation seeking
respectively.
------
J Gambl Stud. 2008 Mar 5 [Epub ahead of print]
Significant Others and Gambling Treatment Outcomes.
Ingle PJ, Marotta J, McMillan G, Wisdom JP.
Department of Public Health and Preventive Medicine, Oregon Health & Science
University, Portland, OR, USA.
Aims This study investigates the effect of significant others on treatment
outcomes among treated pathological gamblers. Design This is a cohort study of
individuals who received gambling treatment. Setting Oregon Problem Gambling
Services (OPGS) for gamblers and their family members. Participants 4,410 adult
gamblers who were discharged from treatment between August, 2001 and April,
2007. Measurements OPGS enrollment forms provided gambler gender, age,
ethnicity, education level, employment status, gambling-related debt, and
whether the gambler had a significant other at the time of enrollment.
Termination forms provided information on the type of discharge
(successful/unsuccessful) and treatment length (in days). Participation of the
gambler's significant other in the family treatment program was identified.
Findings Results showed that age, ethnicity, gambling debt, and having a
significant other are associated with the odds of successful treatment.
Education level moderates the effect of having a significant other on treatment
success. Age, ethnicity, education, employment, and having a significant other
participate in treatment significantly impacted gamblers' length in treatment.
Conclusions These findings indicate that there may be a benefit to integrating
significant others in gambling treatment methods. Significant others may act as
social supports for gamblers seeking treatment, and involving loved ones in
gambling treatment models may positively affect gambler treatment outcomes.
-----
Pharmacol Biochem Behav. 2008 Jan 7 [Epub ahead of print]
A double-blind, placebo-controlled trial of olanzapine for the
treatment of video poker pathological gamblers.
Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L.
David Geffen School of Medicine at UCLA, 760 Westwood Boulevard, Room C8-887,
Los Angeles, CA 90024, United States.
Emerging evidence suggests that dopaminergic and serotonergic functioning are
altered in pathological gamblers; yet, there are no FDA-approved medications for
pathological gambling and there have only been a limited number of clinical
trials that have been conducted. Olanzapine was identified as a candidate
medication for pathological gamblers because it modifies both dopaminergic and
serotonergic function. Moreover, preliminary studies have shown that olanzapine
effectively reduces impulsivity in other psychiatric disorders, a
pharmacological target of interest for pathological gamblers. In this study, 21
pathological gamblers, whose primary gambling activity was video poker, were
enrolled in a seven-week, double-blind, placebo-controlled trial. Outcome
measures included self-reported urges for gambling, frequency of gambling
behavior, and self-reported mood and anxiety levels. The results revealed that
all study participants reported reduced levels of gambling urges, gambling
behavior, and mood and anxiety symptoms. Olanzapine administration was not
associated with an incremental effect versus placebo. While these findings
suggest that olanzapine is not an efficacious treatment for video poker
pathological gamblers, olanzapine may still be an effective treatment for a
specific subset of pathological gamblers, including those with a co-occurring
psychiatric disorder.
-----
J Clin Psychiatry. 2008 Jan 30;:e1-e8 [Epub ahead of print]
Olanzapine in the Treatment of Pathological Gambling: A Negative
Randomized Placebo-Controlled Trial.
McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE.
From the Psychopharmacology Research Program, Department of Psychiatry,
University of Cincinnati College of Medicine (Drs. McElroy, Nelson, Welge, and
Keck and Ms. Kaehler) and Mental Health Service Line and General Clinical
Research Center, Cincinnati Veterans Affairs Medical Center (Dr. Keck),
Cincinnati, Ohio.
OBJECTIVE: Pathological gambling is associated with bipolar disorder and
dopamine dysfunction. Olanzapine is a second-generation antipsychotic with
mood-stabilizing properties and antagonistic activity at several dopamine
receptors. The purpose of this study was to evaluate olanzapine in the treatment
of pathological gambling. METHOD: In this 12-week, single-center, randomized,
double-blind, placebo-controlled, flexible-dose (2.5-15 mg/day) trial, 42
outpatients with pathological gambling by DSM-IV-TR criteria received olanzapine
(N = 21) or placebo (N = 21). The primary outcome measure was the Pathological
Gambling Adaptation of the Yale-Brown Obsessive Compulsive Scale (PG-YBOCS). The
primary analysis of efficacy was a longitudinal analysis of the intent-to-treat
sample, with treatment-by-time interaction as the effect measure. Subjects were
enrolled from June 2, 2000, through November 28, 2005. RESULTS: Compared with
placebo, olanzapine was associated with a similar rate of reduction in total
scores on the PG-YBOCS scale, as well as in gambling episodes/week, hours
gambled/week, and Clinical Global Impressions-Severity of Illness scale scores.
The mean (SD) olanzapine daily dose at endpoint evaluation was 8.9 (5.2) mg/day.
Eleven subjects (52%) receiving olanzapine and 6 (29%) receiving placebo
discontinued prematurely; 3 subjects receiving olanzapine and 2 receiving
placebo discontinued because of adverse events. Events causing olanzapine
discontinuation were pneumonia, sedation, and hypomania. CONCLUSION: Olanzapine
was not superior to placebo in the short-term treatment of pathological
gambling. It was also associated with a high discontinuation rate. TRIAL
REGISTRATION: ClinicalTrials.gov identifier NCT00438776 (http://www.clinicaltrials.gov).
-----
Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):174-6.
[Gambling and suicidal behaviour]
[Article in Norwegian]
Hansen M, Rossow I.
Statens institutt for rusmiddelforskning, Øvre Slottsgate 2b, 0105 Oslo. mh@sirus.no
BACKGROUND: The negative consequences of pathological gambling are related to
social, economical and relational problems. Few studies are available on
possible associations between gambling and suicidal behaviour. Updated
literature reviews are needed. MATERIAL AND METHODS: PsychInfo, ISI and Google
Scholar were searched for relevant literature and 38 publications were found.
RESULTS AND INTERPRETATION: Problem gamblers seeking treatment often report
suicidal thoughts or attempted suicide. Those with suicidal behaviour more often
report mental health problems, alcohol or drug problems, relational difficulties
and financial problems than other problem gamblers. Population surveys suggest
that suicidal behaviour tends to occur more frequently among problem gamblers
than among others. Studies of the association between gambling and suicidal
behaviour at the aggregate level have provided ambiguous results. It is not
clear whether gambling per se may increase the risk of suicidal
behaviour. However, the high prevalence of suicidal behaviour among problem
gamblers suggests that suicide risk should be considered when they present for
treatment.
-----
CNS Drugs. 2008;22(2):123-138.
Pathological Gambling: An Update on Neuropathophysiology and
Pharmacotherapy.
Iancu I, Lowengrub K, Dembinsky Y, Kotler M, Dannon PN.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelPsychiatry B.
Department, Beer Yaakov Mental Health Center, Tel Aviv University, Tel Aviv,
Israel.
Neurobiological research has shown the potential involvement of serotonergic,
dopaminergic and opioid dysfunction in the pathophysiology of pathological
gambling. In this review, we present current theories of the neuropathology of
pathological gambling, paying particular attention to the role of the neural
circuitry underlying motivation, reward, decision-making and impulsivity. This
review also presents a literature review of current pharmacological treatment
strategies for pathological gambling, such as selective serotonin reuptake
inhibitors (SSRIs), opioid receptor antagonists, anti-addiction drugs and mood
stabilizers, and also discusses the role of nonpharmacological interventions.A
hypothetical model of the clinical subtypes of pathological gambling is
presented, e.g. the impulsive subtype, the obsessive-compulsive subtype and the
addictive subtype. This model attempts to integrate current knowledge in the
field of pathological gambling regarding neuropathology, psychiatric
co-morbidity, family history, genetics, course of illness, gender and response
to pharmacological treatment. Finally, it is proposed that the existence of
possible clinical subtypes of pathological gambling may provide a potential
framework for matching the various subtypes with specific pharmacotherapies.
-----
J Gambl Stud. 2007 Dec 20 [Epub ahead of print]
Life Skills, Mathematical Reasoning and Critical Thinking: A
Curriculum for the Prevention of Problem Gambling.
Turner NE, Macdonald J, Somerset M.
Centre for Addiction and Mental Health, 33 Russell Street, T524, Toronto, ON,
Canada, M5S 2S1, Nigel_Turner@camh.net.
Previous studies have shown that youth are two to three times more likely than
adults to report gambling related problems. This paper reports on the
development and pilot evaluation of a school-based problem gambling prevention
curriculum. The prevention program focused on problem gambling awareness and
self-monitoring skills, coping skills, and knowledge of the nature of random
events. The results of a controlled experiment evaluating the students learning
from the program are reported. We found significant improvement in the students'
knowledge of random events, knowledge of problem gambling awareness and
self-monitoring, and knowledge of coping skills. The results suggest that
knowledge based material on random events, problem gambling awareness and
self-monitoring skills, and coping skills can be taught. Future development of
the curriculum will focus on content to expand the students' coping skill
options.
-----
Soc Psychiatry Psychiatr Epidemiol. 2007 Dec 15 [Epub ahead of print]
Gender differences in the associations between past-year gambling
problems and psychiatric disorders.
Desai RA, Potenza MN.
Dept. of Psychiatry and Women and Addictive Disorders, Core of Women’s Health
Research, Yale University School of Medicine, New Haven, CT, USA.
BACKGROUND: Psychiatric disorders frequently co-occur with pathological
gambling. The extent to which co-occurence extends to subsyndromal levels of
gambling or differs between women and men is incompletely understood. AIM: To
examine whether the association between psychiatric disorders and past-year
gambling problems is stronger in women than men. METHODS: Data from the national
epidemiological survey of alcoholism and related disorders (NESARC) (n = 43,093)
were analyzed. RESULTS: Increasing severity of past-year gambling problems was
associated with increasing odds of most past-year Axis I and lifetime Axis II
disorders, regardless of gender. Associations between gambling problems and
major depression, dysthymia, panic disorder, and nicotine dependence were
statistically stronger in women than in men. CONCLUSIONS: A severity-related
association exists between past-year gambling problems and psychiatric
disorders. The stronger associations in women suggest that gambling research,
prevention and treatment efforts consider gender differences.
-----
J Clin Psychopharmacol. 2007 Dec;27(6):620-4.
12-month follow-up study of drug treatment in pathological
gamblers: a primary outcome study.
Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M.
Tel Aviv University, Tel Aviv, Israel. pinhasd@post.tau.ac.il
BACKGROUND: Pathological gambling (PG) is a relatively common and highly
disabling impulse control disorder. A range of psychotherapeutic agents
including selective serotonin reuptake inhibitors, antiepileptic drugs, and
opioid antagonists are shown to be effective in the short-term treatment of PG.
The use of a wide range of pharmacological treatments for PG is consistent with
the observation that PG shares features of obsessive-compulsive spectrum
disorders, impulse control disorders, and addictive disorders. The aim of the
study is to assess the rate of relapse in treatment-responder pathological
gamblers after discontinuation of the active treatment. METHODS: Our study
sample was composed of 43 male pathological gamblers who had been full
responders to 1 of 4 drug treatment regimens (fluvoxamine, topiramate, bupropion
SR, or naltrexone) from several previous acute open-label (12-week) comparison
studies. Full response was defined as the absence of gambling for a 1-month
duration together with improvement on the Clinical Global Improvement scale. The
43 full responders were then followed prospectively for an additional 9 months,
which included a 3-month open-label continuation phase and a 6-month
medication-free follow-up phase. Follow-up visits were performed on a monthly
basis throughout the duration of study. At every follow-up visit, a
comprehensive psychiatric diagnostic evaluation was performed on all patients,
and patients were assessed for symptoms of gambling using a self-report
instrument and collateral family reports. The Clinical Global Impression
Improvement scale was also administered at every follow-up visit. Raters were
blind to the previous drug treatment. RESULTS: Most patients did not relapse
during the 6-month medication-free follow-up phase. Three of 6 patients with
fluvoxamine, 3 of 9 with topiramate, 7 of 18 with bupropion SR, and 4 of 10 with
naltrexone relapsed. Relapse was strictly defined as gambling behavior at any
time during the 6-month medication-free follow-up period. Most of the patients
did not gamble during the follow-up period, and the patients that did gamble
reported a decrease in gambling losses. CONCLUSIONS: This naturalistic long-term
follow-up outcome study demonstrates that among pathological gamblers who
respond to a 6-month trial of medication, most patients seem to maintain
full-response during a 6-month medication-free follow-up phase. Further studies
are needed to confirm our findings.
-----
Rev Bras Psiquiatr. 2007 Oct 31 [Epub ahead of print]
Psychodynamic psychotherapy and the treatment of pathological
gambling.
Rosenthal RJ.
University of California, Los Angeles, USA.
OBJECTIVE: The search for empirically based treatments for pathological gambling
is in its infancy, with relatively few clinical trials and an absence of
naturalistic studies. Treatment retention of gamblers has been a problem;
cognitive-behavioral treatment and pharmacotherapy studies report especially
high dropout rates. Psychodynamic approaches, with their emphasis on the
therapeutic relationship, and the meaning of the patient's self-destructive and
seemingly irrational behaviors, and on obstacles to self-forgiveness, might
improve outcome. METHOD: After a description of psychodynamic psychotherapy, the
literature on both short-term and longer therapies is reviewed regarding their
efficacy for a variety of disorders. With regard to pathological gambling, the
author summarizes the early (1914-1970) psychoanalytic literature then reviews
the more recent psychodynamic psychotherapy literature on pathological gambling.
RESULTS: A review of the recent psychodynamic psychotherapy literature on
pathological gambling failed to disclose a single randomized controlled study of
treatment efficacy or effectiveness. However, there are eight positive outcome
studies described as multi-modal eclectic; half of those seem to utilize
psychodynamic approaches. Two of the more successful programs are described.
CONCLUSIONS:A review of the outcomes literature for psychodynamic psychotherapy
demonstrates efficacy for a variety of disorders sufficient to justify a
clinical trial for pathological gambling. Short-term psychodynamic
psychotherapy, with its focus on core issues, may be particularly applicable to
the pathological gambler's need to avoid or escape intolerable affects and
problems. Longer therapies may be needed to modify an avoidant coping style and
defenses.
-----
Rev Bras Psiquiatr. 2007 Aug 3 [Epub ahead of print]
Cognitive-behavioral treatment for impulse control disorders.
Hodgins DC, Peden N.
Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
OBJECTIVES: This paper reviews the cognitive-behavioral treatment of
kleptomania, compulsive buying, and pathological gambling. METHOD: A review of
the published literature was conducted. RESULTS: Treatment research in all of
these areas is limited. The cognitive-behavioral techniques used in the
treatment of kleptomania encompass covert sensitization, imaginal
desensitization, systematic desensitization, aversion therapy, relaxation
training, and alternative sources of satisfaction. Regarding compulsive buying,
no empirical support for treatment exists but common techniques examined were
covert sensitization, exposure and response prevention, stimulus control,
cognitive restructuring, and relapse prevention. Treatment of pathological
gambling has been successful in both group and individual format using
techniques such as aversive therapy, systematic desensitization, imaginal
desensitization and multimodal behavior therapy (which have included in vivo
exposure, stimulus control, and covert sensitization) along with cognitive
techniques such as psychoeducation, cognitive-restructuring, and relapse
prevention. CONCLUSIONS: There is a general consensus in the literature that
cognitive-behavioral therapies offer an effective model for intervention for all
these disorders. An individualized case formulation is presented with a case
study example. Clinical practice guidelines are suggested for each disorder.
-----
Clin Neuropharmacol. 2007 Jul-Aug;30(4):206-12.
An open-label trial of escitalopram in the treatment of
pathological gambling.
Black DW, Shaw M, Forbush KT, Allen J.
Department of Psychiatry, University of Iowa Roy J. and Lucille A. Carver
College of Medicine, Iowa City, IA 52242, USA. donald-black@uiowa.edu
BACKGROUND: The effectiveness and tolerability of escitalopram was tested in the
treatment of pathological gambling (PG). METHOD: Nondepressed outpatients with
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition PG
received flexibly dosed escitalopram in a prospective, 10-week, open-label trial
after a 2-week observation period. Subjects were evaluated at baseline and at
2-week intervals for assessment of gambling behavior, mood symptoms, and adverse
experiences. The primary efficacy measure was the Yale-Brown
Obsessive-Compulsive Scale modified for PG. Secondary efficacy measures included
the Clinical Global Impression (CGI) Improvement and Severity Scales, a patient
self-rated global rating, the Sheehan Disability Scale, and the Timeline Follow
Back. RESULTS: Nineteen subjects (12 men and 7 women) had at least 1
postbaseline visit and were included in the analysis; 16 subjects (84%)
completed the protocol. Significant improvement was found in all measures,
including the Yale-Brown Obsessive-Compulsive Scale modified for PG, both CGI
Scales, a patient self-rated global scale, the Timeline Follow Back, the
Attention-Deficit/Hyperactivity Disorder Checklist, the Hamilton Depression
Rating Scale, and all 3 Sheehan Disability Scale subscales. Fourteen subjects
(73.7%) were considered responders (ie, achieved "much" or "very much"
improvement on the CGI). Few adverse experiences were reported. CONCLUSION: The
results suggest that escitalopram is well tolerated and may be effective in the
treatment of PG.
-----
J Clin Psychopharmacol. 2007 Aug;27(4):357-364.
Outcome of Pharmacological Treatments of Pathological Gambling: A
Review and Meta-Analysis.
Pallesen S, Molde H, Arnestad HM, Laberg JC, Skutle A, Iversen E, Støylen IJ,
Kvale G, Holsten F.
*Department of Psychosocial Science, University of Bergen, †Bergen Clinics,
Departments of ‡Clinical Psychology and §Psychiatry, University of Bergen,
Bergen, Norway.
Although several qualitative reviews on pharmacological interventions for
pathological gambling have been published, no quantitative review of this field
has been conducted. METHODS:: Studies of pharmacological interventions of
pathological gambling were identified by computer searches in the PsychINFO and
MEDLINE databases covering the period from 1966 to July 2006, as well as from
relevant reference lists. The inclusion criteria were as follows: the target
problem had to be pathological gambling, the interventions were pharmacological,
the study was written in English, and the study reported outcomes particularly
pertaining to gambling. A total of 130 potential studies were identified of
which 16 met the inclusion criteria. A total of 597 subjects were included in
the outcome analyses of these studies. The grand mean age was 43.3 years. The
overall proportion of men was 62.8%. The included studies were coded for outcome
measures of pathological gambling. For each condition, means and SDs for
gambling-related outcome measures were compiled at 2 points in time: baseline
and posttreatment. RESULTS:: At posttreatment, the analysis showed that the
pharmacological interventions were more effective than no treatment/placebo,
yielding an overall effect size of 0.78 (95% confidence interval, 0.64-0.92). A
multiple regression analysis showed that the magnitude of effect sizes at
posttreatment was lower in studies using a placebo-control condition compared
with studies using a predesign/postdesign without any control condition. Effect
sizes were also negatively related to the proportion of male participants in the
included studies. No differences in outcome between the 3 main classes of
pharmacological interventions (antidepressants, opiate antagonists, mood
stabilizers) were detected. CONCLUSION:: Pharmacological interventions for
pathological gambling may be an adequate treatment alternative in pathological
gambling.
-----
Addiction. 2007 Aug;102(8):1280-91.
Do coping skills mediate the relationship between
cognitive-behavioral therapy and reductions in gambling in pathological
gamblers?
Petry NM, Litt MD, Kadden R, Ledgerwood DM.
University of Connecticut Health Center, Farmington, CT, USA.
Aims Cognitive-behavioral therapy (CBT) is useful for treating substance
abusers, and recent data suggest it is also efficacious for pathological
gamblers. CBT is purported to exert its beneficial effects by altering coping
skills, but data supporting coping changes as the mechanism of action are mixed.
This study examined whether coping skills acquisition mediated the effects of
CBT on decreasing gambling in pathological gamblers. Design Participants were
assigned randomly to CBT plus referral to Gamblers Anonymous (GA) or to GA
referral alone. Setting Out-patient clinic. Participants A total of 127
pathological gamblers. Measurements Participants completed the Coping Strategies
Scale (CSS) before treatment and 2 months later; indices of gambling behavior
and problems were administered pretreatment and at months 2 and 12. Findings
Overall, CSS scores increased for participants in both conditions, but those
receiving CBT evidenced larger increases than those in the GA condition (P <
0.05), and they also reduced gambling more substantially between pretreatment
and month 2. Changes in CSS scores mediated the relationship between treatment
assignment and gambling outcomes from pretreatment to month 2, but little
evidence of mediation occurred for the long-term follow-ups. Conclusions CBT's
beneficial effects in decreasing gambling may be related partly to changes in
coping responses, and improvements in coping are associated with long-term
changes in gambling. However, relationships between coping skills and gambling
behavior are fairly strong, regardless of treatment received.
-----
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001521.
Interventions for pathological gambling.
Oakley-Browne M, Adams P, Mobberley P.
BACKGROUND: With the legalization of new forms of gambling there are increasing
numbers of individuals who appear to have gambling related problems and who are
seeking help. The individual and societal consequences are significant.
Pathological gambling can result in the gambler jeopardizing or losing a
significant relationship or job and committing criminal offences. Pathological
gamblers may develop general medical conditions associated with stress.
Increased rates have been reported for mood disorders,
attention-deficit/hyperactivity disorder, substance abuse or dependence. There
is a high risk of suicide and a high correlation with antisocial, narcissistic
and borderline personality disorders and alcohol addiction. With increasing
public awareness of gambling related problems health funders and practitioners
are asking questions about the efficacy of treatments. Consequently quality
research into gambling treatment is crucial. OBJECTIVES: The objective of this
review was to complete a systematic review and meta-analysis of all randomised
controlled trials (RCTs) of psychological and pharmacological treatments for
pathological gambling, from both published and unpublished scientific reports.
SEARCH STRATEGY: Published and unpublished RCTs of treatments of pathological
gambling were identified by searches of electronic databases and hand searching
journals likely to contain RCTs of gambling treatments. Researchers and gambling
treatment centres were contacted by letter. Bibliographies of all identified
research studies were scanned to identify other relevant references. SELECTION
CRITERIA: All RCTs of treatments for pathological gambling were eligible for
inclusion. DATA COLLECTION AND ANALYSIS: The data was entered into the Cochrane
Review Manager software (REVMAN). The component RCTs were quality rated, with
special emphasis on the concealment of treatment allocation and blinding.
Relative risk analyses were conducted for the dichotomous outcome of controlled
vs. uncontrolled gambling. The relative risks were aggregated using both fixed
and random effects models. Tests for heterogeneity were undertaken. Both
short-term (1 month or less) and long-term (6 months or longer) outcomes were
considered. MAIN RESULTS: Only four RCTs of psychological treatments were
identified. These RCTs were heterogeneous in terms of design, interventions,
outcome measurement and follow-up periods. All had small numbers of
participants. The studies had poor methodological quality features. The
experimental interventions, behavioural or cognitive-behavioural therapy (BT/CBT),
were more efficacious than the control interventions in the short-term (relative
risk 0.44, 95% confidence interval (CI) 0.24-0.81). There was a trend for
long-term treatment with BT/CBT to be more efficacious than the control
treatments, but the statistical significance of this was sensitive to the
statistical model used for meta-analysis. With a fixed effect model the relative
risk was 0.56 (95% CI 0.33-0.95); the relative risk with a random effects model
was 0.61 (95% CI 0.25-1.47). AUTHORS' CONCLUSIONS: This systematic review
revealed a paucity of evidence for effective treatment of pathological gambling.
As gambling is becoming more accessible in many countries and there is
epidemiological evidence of increasing rates of pathological gambling, more
rigorous RCTs are required.
-----
Cogn Behav Ther. 2007;36(2):74-84.
Prevention of pathological gambling: a randomized controlled
trial.
Doiron JP, Nicki RM.
Psychology Department, University of Prince Edward Island, Charlottetown, Prince
Edward Island, Canada. jpdoiron@upei.ca
Although the gambling industry is expanding rapidly throughout North America and
around the world, there are only a few empirically evaluated programs aimed at
the prevention of pathological gambling (PG). The purpose of this study was to
measure the effectiveness of a new prevention program aimed at PG. The Stop &
Think! program was designed to teach at-risk video lottery terminal (VLT)
gamblers cognitive restructuring and problem-solving skills that may help to
prevent the development of PG. These skills were taught through a variety of
methods - including an automated educational presentation, video and text
vignettes, audio training tapes, and skill rehearsal. The program was evaluated
using a randomized, 2-group experimental design with a wait-list control group
and pre-, post-, and follow-up measures. Results indicated that, compared with
the control group, the experimental group was less at risk for developing a
gambling problem after the program. The experimental group endorsed fewer
gambling-related cognitive distortions, engaged in less VLT gambling, and had
lower scores on a measure of PG. The results of this study provide the basis for
the implementation of the Stop & Think! program in the province of Prince Edward
Island, Canada, and perhaps other jurisdictions too.
-----
Curr Treat Options Neurol. 2007 May;9(3):189-97.
Management of impulse control disorders in Parkinson's disease.
Galpern WR, Stacy M.
Mark Stacy, MD Duke University Medical Center, Division of Neurology, 932
Morreene Road, MS 3333, Durham, NC 27705, USA. stacy002@mc.duke.edu.
Impulse control disorders (ICDs) are a set of behaviors, including pathologic
gambling, hypersexuality, compulsive shopping, compulsive eating, and punding,
which are now recognized to occur in a subset of patients with Parkinson's
disease (PD). Although the underlying pathophysiology of these behaviors is
poorly understood, they appear to be associated with the use, and sometimes
overuse, of dopaminergic agents prescribed for the treatment of the motor
symptoms of PD. At present, there are limited data to support any particular
therapeutic strategy. Approaches worth considering in the management of the PD
patient with an ICD include reduction or discontinuation of dopamine agonist
therapy, trials of various pharmacologic agents, psychosocial interventions, and
deep brain stimulation of the subthalamic nucleus. However, the management of
each patient must be tailored for the particular clinical setting, and the
development of evidence-based treatment strategies awaits future prospective
studies and randomized controlled trials.
-----
J Clin Psychopharmacol. 2007 Apr;27(2):143-150.
Bupropion in the Treatment of Pathological Gambling: A
Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study.
Black DW, Arndt S, Coryell WH, Argo T, Forbush KT, Shaw MC, Perry P, Allen J.
*Department of Psychiatry, University of Iowa Roy J. and Lucille A. Carver
College of Medicine; daggerDepartment of Biostatistics, University of Iowa
College of Public Health, Iowa City, IA; double daggerDivision of Pharmacy
Practice, University of Texas College of Pharmacy, Austin, TX; section
signDepartment of Psychology, University of Iowa College of Liberal Arts and
Sciences, and parallelUniversity of Iowa College of Pharmacy, Iowa City, IA.
We tested the efficacy of bupropion in the treatment of persons with
pathological gambling (PG). Nondepressed, healthy subjects with Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition PG were randomly assigned
to placebo or flexibly dosed bupropion in a 12-week double-blind trial. Outcome
measures included the Yale-Brown Obsessive-Compulsive Scale modified for PG, the
Gambling Severity Assessment Scale, the Clinical Global Impression Improvement
and Severity Scales, the Global Assessment Scale, the Timeline Follow Back, the
Attention-Deficit/Hyperactivity Disorder Rating Scale, and the Sheehan
Disability Scale. Thirty-nine subjects (28 men, 11 women) were randomized to
bupropion (n = 18) or placebo (n = 21). The 2 groups were similar on demographic
and clinical measures. There were few differences between the treatment groups
on any primary or secondary outcome measure, although subjects in each cell
experienced significant improvement. Of subjects with at least 1
postrandomization visit, 35.7% of bupropion and 47.1% of placebo recipients
experienced "much" or "very much" improvement on the Clinical Global Impression
Improvement Scale. The trial was complicated by a high noncompletion rate
(43.6%). Bupropion was well tolerated. Bupropion and placebo recipients did
equally well in a short-term trial, with improvement seen as early as the first
week of treatment. The high placebo response rate and the high noncompletion
rate each reflect the challenge inherent in treating persons with PG.
-----
J Gambl Stud. 2007 Mar 9; [Epub ahead of print]
Vulnerability and Comorbidity Factors of Female Problem Gambling.
Boughton R, Falenchuk O.
Problem Gambling Service, Center for Addiction and Mental Health, 175 College
Street, Toronto, ON, Canada, M5T 1P7, Roberta_Boughton@CAMH.net.
This study helps to address a deficiency of gender-specific research into
problem gambling. It focuses on the gambling behaviors, family and personal
histories and comorbid psychological disorders of 365 female gamblers from
across Ontario, Canada, who responded to a mail-in survey. Specifically, this
study looks at rates of depression and anxiety, concurrent struggles with other
behaviors (such as alcohol and drug use, disordered eating, overspending and
criminal activity) and abuse history reported by female gamblers. The reported
rates are considerably higher than for the general female population. The
findings of this study agree with previous research. They suggest that
prevention strategies and treatment practices for female problem gamblers should
take into account women's mental health, addiction and trauma history as
contributing factors in the development of problematic gambling.
-----
J Gambl Stud. 2007 Mar;23(1):41-54.
Does providing extended relapse prevention bibliotherapy to
problem gamblers improve outcome?
Hodgins DC, Currie SR, El-Guebaly N, Diskin KM.
Department of Psychology, University of Calgary, 2500 University Drive NW,
Calgary, AB, Canada, T2N 1N4, dhodgins@ucalgary.ca.
Relapse rates among pathological gamblers are high with as many as 75% of
gamblers returning to gambling shortly after a serious attempt to quit. The
present study focused on providing a low cost, easy to access relapse prevention
program to such individuals. Based on information collected in our ongoing study
of the process of relapse, a series of relapse prevention booklets were
developed and evaluated. Individuals who had recently quit gambling (N = 169)
were recruited (through media announcements) and randomly assigned to a single
mailing condition in which they received one booklet summarizing all of the
relapse prevention information or a repeated mailing condition in which they
received the summary booklet plus 7 additional booklets mailed to them at
regular intervals over the course of a year period. Gambling involvement over
the course of the 12-month follow-up period, confirmed by family or friends, was
compared between the two groups. Results indicated that participants receiving
the repeated mailings were more likely to meet their goal, but they did not
differ from participants receiving the single mailing in frequency of gambling
or extent of gambling losses. The results of this project suggest that providing
extended relapse prevention bibliotherapy to problem gamblers does not improve
outcome. However, providing the overview booklet may be a low cost, easy to
access alternative for individuals who have quit gambling.
-----
J Gambl Stud. 2007 Mar;23(1):85-94.
Self-exclusion program: a longitudinal evaluation study.
Ladouceur R, Sylvain C, Gosselin P.
School of Psychology, Laval University, Quebec, Quebec, Canada, G1K 7P4,
robert.ladouceur@psy.ulaval.ca.
Few self-exclusion programs have been evaluated and their long-term impact
remains unknown. This study has two main goals: (1) to assess changes in
gambling behaviour and gambling problems for self-excluded patrons, and (2) to
follow self-excluded gamblers for a two-year period (during and after the
self-exclusion period). Individuals who excluded themselves (N = 161 at the
initial stage) participated in telephone interviews after signing the
self-exclusion agreement and were followed at 6, 12, 18 and 24-months. Results
show that according to the DSM-IV, 73.1% of the participants were pathological
gamblers. The self-exclusion program has many positive effects. During the
follow-ups, the urge to gamble was significantly reduced while the perception of
control increased significantly for all participants. The intensity of negative
consequences for gambling was significantly reduced for daily activities, social
life, work, and mood. The DSM score was significantly reduced over time. This
reduction also took place between the baseline and the 6-month follow-up. The
clinical implications of the results are discussed in relation to the
effectiveness of the program. Suggestions are provided in order to increase
compliance of self-excluded patrons.
-----
J Gambl Stud. 2007 Jan 24; [Epub ahead of print]
Minimal Treatment Approaches for Concerned Significant Others of
Problem Gamblers: A Randomized Controlled Trial.
Hodgins DC, Toneatto T, Makarchuk K, Skinner W, Vincent S.
Department of Psychology, University of Calgary, 2500 University Drive N.W.,
Calgary, AB, Canada, T2N1N4, dhodgins@ucalgary.ca.
The goal of this study was to examine the efficacy of minimal treatment
interventions for concerned significant others (CSOs) of problem gamblers. One
hundred and eighty-six participants (82% females, 56% spouses) were randomly
assigned to one of three groups: the first minimal intervention group received a
self-help workbook [based on behavioral principles, modified from the Community
Reinforcement and Family Therapy (CRAFT) model] and the second minimal
intervention group received the workbook plus telephone support. The control
condition received a treatment resource information package. Overall, all
participants reported significant improvement in personal and relationship
functioning and gambling behavior and consequences at the 3- and 6-month
follow-up. The data demonstrated differences in favor of the interventions in
three areas: days gambling, satisfaction with the program, and number who had
their needs met. There was no difference in the number who had entered
treatment. It may be that CSOs require more guidance and follow-up support to
achieve these goals using the CRAFT procedures and strategies.
-----
Expert Rev Neurother. 2006 Dec;6(12):1845-51.
Pharmacotherapy of pathological gambling: review of new treatment
modalities.
Lowengrub K, Iancu I, Aizer A, Kotler M, Dannon PN.
Ness Ziona and Beer Ya'akov Medical Complex and Tel Aviv University, The Rehovot
Community Mental Health & Rehabilitation Center, Remez Street 80, Rehovot,
76449, Israel. jalow@netvision.net.il
Pathological gambling is classified in the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition as an impulse-control disorder. In the
International Classification of Diseases of the WHO, pathological gambling is
coded under the heading of 'Habit and Impulse Disorders'. Pathological gambling
is a chronic, progressive disorder, which has a prevalence of 1-3.4% among
western civilizations. The enormous personal and social consequences of this
disorder include a high rate of suicide attempts, job loss, marital and family
problems, legal problems, and criminal behavior. Recent studies have
demonstrated that pathological gambling patients respond well to treatment with
selective serotonin reuptake inhibitors, mood stabilizers and opioid
antagonists. These findings support the idea that pathological gambling and
other disorders of impulse control may be conceptualized as part of the
obsessive-compulsive spectrum disorders or addictive disorders. This article
will discuss possible treatment strategies according to different behavior
patterns in pathological gambling and also remind the physicians who intend to
treat this disorder of the possible diagnosis of pathological gambling.
Previous Compulsive Gambling
Research: 2002-2006
The
Compulsive Gambling
File also contains summaries of past
research that has shown promise and may still be standard
practice among many physicians.
To
download earlier
research findings on
Compulsive Gambling, click
HERE.
©Copyright 1992-date by The Center
for Current Research. The Compulsive Gambling File is a proprietary
compilation of the Center for Current Research. The information
in the File is solely for your use, and the use of your family,
friends, and doctors. The information is the property of the individual
researchers and institutions that produced it. It is an infringement
of copyright law to attempt to "resell" the information
as it is presented here.
|